BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34073780)

  • 21. Design and evaluation of hyaluronic acid-coated PLGA nanoparticles of raloxifene hydrochloride for treatment of breast cancer.
    Bhatt K; Patil P; Jani P; Thakkar P; Sawant K
    Drug Dev Ind Pharm; 2021 Dec; 47(12):2013-2024. PubMed ID: 35686735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piceatannol-Loaded Emulsomes Exhibit Enhanced Cytostatic and Apoptotic Activities in Colon Cancer Cells.
    Alhakamy NA; Badr-Eldin SM; Ahmed OAA; Asfour HZ; Aldawsari HM; Algandaby MM; Eid BG; Abdel-Naim AB; Awan ZA; Alghaith AF; Alaofi AL; Mohamed AI; Okbazghi SZ; Al-Rabia MW; Fahmy UA
    Antioxidants (Basel); 2020 May; 9(5):. PubMed ID: 32414040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposing of atorvastatin emulsomes as a topical antifungal agent.
    Eita AS; M A Makky A; Anter A; Khalil IA
    Drug Deliv; 2022 Dec; 29(1):3414-3431. PubMed ID: 36428290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and Evaluation of a Self-Microemulsifying Drug Delivery System of Raloxifene with Improved Solubility and Oral Bioavailability.
    Ansari MM; Vo DK; Choi HI; Ryu JS; Bae Y; Bukhari NI; Zeb A; Kim JK; Maeng HJ
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovariectomy-Induced Mitochondrial Oxidative Stress, Apoptosis, and Calcium Ion Influx Through TRPA1, TRPM2, and TRPV1 Are Prevented by 17β-Estradiol, Tamoxifen, and Raloxifene in the Hippocampus and Dorsal Root Ganglion of Rats.
    Yazğan Y; Nazıroğlu M
    Mol Neurobiol; 2017 Dec; 54(10):7620-7638. PubMed ID: 27832523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface-tailoring of emulsomes for boosting brain delivery of vinpocetine via intranasal route:
    Aldawsari HM; Badr-Eldin SM; Assiri NY; Alhakamy NA; Privitera A; Caraci F; Caruso G
    Drug Deliv; 2022 Aug; 29(1):2671-2684. PubMed ID: 35975309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of Liposomal Raloxifene-Graphene Nanosheet and Evaluation of Its
    Altyar AE; Fahmy O
    Dose Response; 2022; 20(1):15593258211063983. PubMed ID: 35069050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of intravaginal rod insert bearing liposomal raloxifene hydrochloride and Leuprolide acetate as a potential carrier for uterine targeting.
    Patel A; Dhande R; Thakkar H
    J Pharm Pharmacol; 2021 Mar; 73(5):653-663. PubMed ID: 33772288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Green Nanotechnology in the Formulation of a Novel Solid Dispersed Multilayered Core-Sheath Raloxifene-Loaded Nanofibrous Buccal Film; In Vitro and In Vivo Characterization.
    Nageeb El-Helaly S; Abd-Elrasheed E; Salim SA; Fahmy RH; Salah S; El-Ashmoony MM
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33915828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring cytotoxicity of cordycepin loaded nanovesicles against (HCT116) colon cancer cells: Optimization and cellular evaluation.
    Alhakamy NA; Fahmy UA
    Biomed Pharmacother; 2022 Oct; 154():113619. PubMed ID: 36081285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the treatment potential of Raloxifene-loaded polymeric nanoparticles in osteoporosis: In-vitro and in-vivo analyses.
    Guo Z; Afza R; Moneeb Khan M; Khan SU; Khan MW; Ali Z; Batool S; Din FU
    Heliyon; 2023 Sep; 9(9):e20107. PubMed ID: 37810010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly (ε-caprolactone) nanocapsules for oral delivery of raloxifene: process optimization by hybrid design approach, in vitro and in vivo evaluation.
    Aditya N; Ravi PR; Avula US; Vats R
    J Microencapsul; 2014; 31(5):508-18. PubMed ID: 24697167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced bioavailability of raloxifene hydrochloride via dry suspensions prepared from drug/HP-β-cyclodextrin inclusion complexes.
    Lu R; Liu S; Wang Q; Li X
    Pharmazie; 2015 Dec; 70(12):791-7. PubMed ID: 26817276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-Nanoemulsifying Drug Delivery System of 2-Methoxyestradiol Exhibits Enhanced Anti-Proliferative and Pro-Apoptotic Activities in MCF-7 Breast Cancer Cells.
    Al-Qahtani SD; Bin-Melaih HH; Atiya EM; Fahmy UA; Binmahfouz LS; Neamatallah T; Al-Abbasi FA; Abdel-Naim AB
    Life (Basel); 2022 Sep; 12(9):. PubMed ID: 36143405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoemulsomes for Enhanced Oral Bioavailability of the Anticancer Phytochemical Andrographolide: Characterization and Pharmacokinetics.
    Elsheikh MA; Rizk SA; Elnaggar YSR; Abdallah OY
    AAPS PharmSciTech; 2021 Oct; 22(7):246. PubMed ID: 34617166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms.
    Abo El-Enin HA; Mostafa RE; Ahmed MF; Naguib IA; A Abdelgawad M; Ghoneim MM; Abdou EM
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinically favorable effects of raloxifene on bone mineral density and serum lipids: population assessment via bivariate analysis.
    Shah A; Iversen P; Mitlak B
    Prim Care Update Ob Gyns; 1998 Jul; 5(4):165-166. PubMed ID: 10838310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.
    Kushwaha AK; Vuddanda PR; Karunanidhi P; Singh SK; Singh S
    Biomed Res Int; 2013; 2013():584549. PubMed ID: 24228255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
    Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
    Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.